Psychopharmacological and analgesic action of selective serotonin reuptake inhibitor antidepressants fluoxetine in female mouse

被引:0
|
作者
Cobo-Realpe L. [1 ]
Collazos C.A. [2 ]
Castellanos H.E. [2 ]
Herrera-Mendoza K. [3 ]
机构
[1] Grupo Biopsiquismo y Sociedad, Universidad Manuela Beltrán, Bogotá D.C
[2] Grupo de Ciencias Básicas y Laboratorios, Universidad Manuela Beltrán, Bogotá D.C.
[3] Grupo de Investigación Cultura, Educación y Sociedad, Programa de psicología, Universidad de la Costa CUC, Barranquilla
来源
Informacion Tecnologica | 2020年 / 31卷 / 03期
关键词
Analgesic; Antidepressant; Fluoxetine; Selective serotonin reuptake inhibition;
D O I
10.4067/S0718-07642020000300039
中图分类号
学科分类号
摘要
The main objective of this paper is to establish the potency range and the action mechanism of selective serotonin reuptake inhibition (SSRI) fluoxetine on female CD-1 mice (25-39 kg). Our results indicated that fluoxetine´s antidepressant doses of 16 mg/kg (i.p.), 32 mg/kg (i.p.), and 64 mg/kg (i.p.) had an analgesic and anxiolytic effect without significant results on the spatial memory test. Reduced activity on memory work on specific activities was only observed with a dose of 64 mg/kg (i.p.). This is evidence to suggest that fluoxetine can be more effective with doses that showed an antidepressant effect. It also indicates that fluoxetine can have an analgesic and anxiolytic effect without reducing motor activity on mice. The maximum dose tested on this study showed variations on motor activity of mice suggesting that SSRI fluoxetine can have sedative effects. © 2020 Centro de Informacion Tecnologica. All rights reserved.
引用
收藏
页码:39 / 50
页数:11
相关论文
共 50 条
  • [31] Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms
    Redrobe, JP
    Bourin, M
    Colombel, MC
    Baker, GB
    JOURNAL OF PSYCHOPHARMACOLOGY, 1998, 12 (04) : 348 - 355
  • [32] Tricyclic antidepressants, but not the selective serotonin reuptake inhibitor fluoxetine, bind to the S1S2 domain of AMPA receptors
    Gentile, Lisa Nancy
    Seguin, Sandlin
    Stoll, Laura
    FASEB JOURNAL, 2007, 21 (05): : A43 - A43
  • [33] Tolerability of Serotonin Norepinephrine Reuptake Inhibitor Antidepressants
    Montgomery, Stuart A.
    CNS SPECTRUMS, 2008, 13 (07) : 27 - 33
  • [34] Review of cardiovascular effects of fluoxetine, a selective serotonine reuptake inhibitor, compared to tricyclic antidepressants
    Pacher, P
    Ungvari, Z
    Kecskemeti, V
    Furst, S
    CURRENT MEDICINAL CHEMISTRY, 1998, 5 (05) : 381 - 390
  • [35] How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
    Hall, Wayne D.
    Lucke, Jayne
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2006, 40 (11-12): : 941 - 950
  • [36] Selective serotonin reuptake inhibitor antidepressants: Cardiovascular complications - Sorting through findings
    Shader, RI
    Greenblatt, DJ
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (05) : 467 - 468
  • [37] Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture
    Hubbard, R
    Farrington, P
    Smith, C
    Smeeth, L
    Tattersfield, A
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (01) : 77 - 84
  • [38] Drug interactions with antidepressants. Advantages of the selective serotonin reuptake inhibitor citalopram
    Eckert, A
    Reiff, J
    Muller, WE
    PSYCHOPHARMAKOTHERAPIE, 1998, 5 (01): : 8 - 18
  • [39] Selective serotonin and norepinephrine reuptake inhibitors (SSNRI) -: antidepressants with a dual mode of action
    Müller, WE
    Haen, E
    Fritze, J
    Rüther, E
    Laux, G
    Bauer, M
    Möller, HJ
    PSYCHOPHARMAKOTHERAPIE, 2004, 11 (03): : 71 - 75
  • [40] The new antidepressants - Selective serotonin reuptake inhibitors
    Labellarte, MJ
    Walkup, JT
    Riddle, MA
    PEDIATRIC CLINICS OF NORTH AMERICA, 1998, 45 (05) : 1137 - +